Sonoma Pharmaceuticals (SNOA) Exchange Rate Effect (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Exchange Rate Effect of $127000.0 in Q4 2025, down 7.3% quarter-over-quarter from $137000.0 in Q3 2025, and up 212.39% on a YoY basis from $40654.4 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Exchange Rate Effect (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Exchange Rate Effect history runs 16 years deep, the most recent figure standing at $127000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 212.39% year-over-year to $127000.0; the TTM figure through Dec 2025 stood at $712000.0 (up 198.34% YoY), while the FY2025 annual figure was -$616000.0, down 2025.0% from the prior year.
- Exchange Rate Effect was $127000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from $137000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $410000.0 in Q2 2025 to a low of -$283000.0 in Q3 2024.
- Historically, Exchange Rate Effect has averaged $23789.5 across 5 years, with a median of $38000.0 in 2025.
- The sharpest annual moves came in 2021 and 2024: Exchange Rate Effect soared 453.85% in 2021, then tumbled 528.89% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at -$46000.0 in 2021, then sank by 84.78% to -$85000.0 in 2022, then soared by 165.88% to $56000.0 in 2023, then slumped by 301.79% to -$113000.0 in 2024, then soared by 212.39% to $127000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $127000.0 (Q4 2025), $137000.0 (Q3 2025), and $410000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | 127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | -113,000.00 |
| Dec 31, 2024 | -113,000.00 |
| Sep 30, 2024 | -283,000.00 |
| Sep 30, 2024 | -283,000.00 |
| Jun 30, 2024 | -258,000.00 |
| Jun 30, 2024 | -258,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | -45,000.00 |
| Sep 30, 2023 | -45,000.00 |